ABSTRACT Aim: This study evaluated the incidence and risk factors for intensive care and respiratory support in infant bronchiolitis.
INTRODUCTION
Bronchiolitis is the most common infectious cause of hospitalisation in infants. Most bronchiolitis patients have an uneventful course treated at home, but about 3% of those under 24 months of age are hospitalised (1,2) and 2-3% of those hospitalised need mechanical ventilation (3) . A Finnish study found that 37 per 1000 infants aged less than six months were admitted to the emergency department (ED) each year due to viral bronchiolitis and 70% of them were hospitalised, which was the equivalent of 2.6% of all infants. Furthermore, 6.1% needed treatment in the paediatric intensive care unit (PICU), which equated to an incidence of 2.3/1000/year in this age-specific population (4) . Another Finnish study found that the rate of PICU treatment was 6.3% among those admitted to the ED due to bronchiolitis at less than 12 months of age (5) .
Previous studies have identified several risk factors for severe bronchiolitis requiring hospitalisation, such as prematurity, young age, environmental factors like passive smoking and crowded households and underlying diseases like chronic lung disease, congenital heart disease (CHD) and some neurological syndromes (3, 6) . Likewise, previous studies have identified risk factors associated with severe bronchiolitis requiring mechanical ventilation, such as being under two months of age, maternal smoking during pregnancy, Caesarean section delivery, a birthweight of less than 2300 g, apnoea, inadequate oral intake, an oxygen saturation of less than 85% in room air and a respiratory rate of more than 70 breaths per minute (7) (8) (9) . However, these previous prospective studies from the United States comprised infants who were over 12 months of age and Abbreviations 95% CI, 95% confidence intervals; aOR, Adjusted odds ratio; CHD, Congenital heart disease; ED, Emergency department; HFNC, High-flow nasal cannula; IQR, Interquartile range; nCPAP, Nasal continuous positive airway pressure; OR, Odds ratio; PICU, Paediatric intensive care unit.
Key notes
This study evaluated the incidence and risk factors for intensive care and respiratory support in 105 infants with bronchiolitis admitted to the paediatric intensive care unit (PICU). We found that less than 0.1% of infants under 12 months of age were admitted to the PICU for bronchiolitis. Low age, low birthweight or prematurity and congenital heart disease were independently significant risk factors for both intensive care and respiratory support.
those with recurrent wheeze (7, 8, 10) , which do not fit the current European definition of bronchiolitis (11) .
The aim of this retrospective case-control study was to evaluate the incidence of, and the risk factors for, intensive care and respiratory support in infants admitted to a Finnish hospital for bronchiolitis at less than 12 months of age in 2000-2015.
PATIENTS AND METHODS
This one-centre, case-control study was based on a retrospective review of the electronic patient files of Tampere University Hospital, Tampere, Finland, for the years 2000-2015 (12) . It was carried out with the permission of the Chief Physician of the University Hospital. At the time of the study, the hospital provided inpatient care for a population of about 90 000 children aged less than 16 years and the population of infants aged less than 12 months ranged from 4761 to 5880. In addition, the hospital provided paediatric intensive care for a population of about 10 000 infants aged less than 12 months from four surrounding central hospitals (12) . All the central hospitals surrounding the University Hospital had facilities to provide noninvasive ventilation support, such as nasal continuous positive airway pressure (nCPAP) during the surveillance period. High-flow nasal cannula (HFNC) treatment was introduced to the PICU at Tampere University Hospital in 2011 and to the paediatric ward in 2012.
We identified all patients treated in the PICU at less than 12 months of age with the International Classification of Diseases -10th edition (ICD-10) codes of J10*-18*, J20*-22*, J45*or J46* during 2000-2015. One of the authors (PH) reviewed the 179 patient files that were identified, checked the established diagnoses and the registered clinical findings and assessed the final bronchiolitis diagnoses for this study. Bronchiolitis was defined as the first episode of expiratory breathing difficulty, with or without audible wheezing, associated with a lower respiratory tract infection (12) . We excluded 11 infants with recurrent wheezing, one with blood culture-positive bacterial infections and 26 with tense alveolar infiltrates in chest radiographs on admission that suggested bacterial pneumonia. In addition, 36 infants were treated in the PICU for some other reason than bronchiolitis. The chart review showed that 105 infants had bronchiolitis as their main diagnosis or treating bronchiolitis was the main reason they received intensive care, and 83 bronchiolitis patients were from the Pirkanmaa (Tampere) Hospital District. Of the 105 cases, 34 infants were treated first on the paediatric ward and 71 were admitted directly to the PICU, including 22 patients from other surrounding hospitals. Infants were admitted to the PICU if they had acute worsening of their breathing, such as an increasing need of supplementary oxygen or increasing respiratory work, or recurrent apnoea. The indications for PICU admission were the same for infants transferred from the surrounding hospitals and for those transferred from the wards or the ED of the University Hospital.
We selected two controls for each of these 105 cases, who were admitted for bronchiolitis with ICD-10 codes J21* just before and after the case. The controls were not admitted to the PICU and 146 of them were treated as inpatients on the ward and 64 as outpatients in the ED. One of the authors (PH) reviewed the hospital records of the 105 cases and 210 controls and completed the same structural form to collect medical data on both groups. This was carried out separately for findings and treatments in the ED, on the ward, and in the PICU.
The data we collected comprised information on gender, gestational age classified with the cut-off points of 28, 32 and 37 weeks, birthweight and age and weight on admission for bronchiolitis. We also included the previous medical history, such as presence of respiratory distress syndrome, bronchopulmonary dysplasia, CHD, treatment with surfactant as a neonate and the use of inhaled corticosteroids at a later date. In addition, we looked at possible previous hospital admissions, including treatment periods in the neonatal intensive care unit, the presence of atopy -such as doctor-diagnosed atopic dermatitis or a food allergy -and family histories of atopy or asthma. Any presence of audible wheezing, fine or coarse crackles on auscultation and dehydration was recorded on admission. The results of any available viral antigen tests were collected. Secondary infections during hospitalisation, such as otitis media, conjunctivitis and pneumonia, were recorded. Any therapies with nCPAP and mechanical ventilation were also recorded and both were considered as respiratory support. Apnoea was defined as breathing pause, with or without bradycardia and desaturation, detected and recorded by the medical staff.
Statistical methods IBM SPSS Statistics, version 23 (SPSS Inc., Chicago, IL, USA) was used to analyse the data. The chi-square test and the frequency and percentage distributions with 95% confidence intervals (95% Cl) were used in the univariate statistical calculations. Two-tailed p < 0.05 was considered statistically significant. We used the Bonferroni correction by multiplying p-values by two in paired comparisons. Continuous variables were presented as medians with interquartile ranges (IQR). Odds ratios (OR) and their 95% Cls were calculated first as nonadjusted and then in the multivariable logistic regression as adjusted ORs (aOR) for age, gender and risk factors that were significant in the nonadjusted analyses. Previous hospitalisation and the previous use of corticosteroids were related to prematurity, and therefore, they were excluded from the final multivariable analyses. Even though several clinical findings were statistically significant in the nonadjusted analyses, we decided to only add wheezing sound to the final multivariable analyses, due to its clear definition in Finnish clinical practice.
RESULTS
The median age was 1.7 months (IQR 0.9-3.5) in the 105 infants in the PICU bronchiolitis group and 4.0 months (IQR 2.1-6.1) in the 210 infants in the control bronchiolitis group (p < 0.001). Their basic characteristics are presented in Table 1 . Compared to the control group, infants treated in the PICU were younger and presented with higher comorbidities. They were also more likely to have been born premature, had lower birthweights and previously been treated more frequently in the hospital (Table 1 ). The risk of being admitted to the PICU was higher in infants aged less than two months (OR 5.0, 95% Cl: 3.0-8.4), born at <37 weeks (OR 7.2, 95% Cl: 4.0-13.0), with a birthweight under 2500 g (OR 14.6, 95% Cl: 6.7-31.9) and with apnoea (OR 39.7, 95% Cl: 9.3-170.3) ( Table 1) .
As expected, the same characteristics were associated with the need for respiratory support, including nCPAP and, or, mechanical ventilation during their PICU stay, as for PICU admission (Table S1 ). The risk for respiratory support was higher in infants aged less than two months (OR 3.8, 95% Cl: 2.0-7.2), those born preterm at less than 37 weeks (OR 6.7, 95% Cl: 3.3-13.5), with a birthweight under 2500 g (OR 8.7, 95% Cl: 4.2-18.1) and CHD (OR 5.0, 95% Cl: 1.9-15.1).
Wheezing was associated with a lower risk of PICU admission (OR 0.3, 95% CI: 0.2-0.5) and lower need for respiratory support (OR 0.4, 95% CI: 0.2-0.7) in those admitted (Tables 1 and S1 ).
Apnoea was strongly associated with admission to the PICU (OR 39.7, 95% Cl: 9.3-170.3) and with the need for respiratory support (OR 6.7, 95% Cl: 3.0-15.0; Tables 1 and  S1 ). In fact, apnoeas were only reported in one patient in the control group. In all, 40 infants presented with apnoea during their hospital stay and 40% of them needed respiratory support in the PICU (Table S2 ). Statistically significant risk factors for apnoea in inpatients were being less than two months of age (OR 5.4, 95% Cl: 2.6-10.9), being (Table 2 ).
In the multivariable logistic regression, the independently significant risk factors for needing respiratory support, namely mechanical ventilation or nCPAP, were being less than two months of age (aOR 10.2, 95% CI: 3.0-33.8), having a low birthweight of less than 2000 g (aOR 4.9, 95% CI: 1.1-21.4) and CHD (aOR 13.0, 95% CI: 2.8-60.9). Apnoea, preterm birth and the absence of wheezing lost their statistical significance ( Table 3) .
As 46% of the PICU admissions were associated with premature birth, we performed supplementary analyses by excluding birthweight from the model. In this model, premature birth was an independently significant risk factor for PICU admissions (aOR 4.4, 95% CI: 1.2-9.8) and respiratory support (aOR 3.8, 95% CI: 1.7-8.9).
The annual number of the patients with bronchiolitis varied between 1 and 14. The mean number of children aged less than 12 months in the population was 5335 and varied between 4761 and 5880. These figures allowed us to calculate the population-based incidences. The age-specific annual incidence varied considerably, from 0.18/1000/year to 2.59/1000/year, with a mean of 1.5 ( Figure 1 ).
DISCUSSION
There were four main results in this 16-year retrospective, one-centre, case-control study on the need for intensive care in infants with bronchiolitis at less than 12 months of age. First, the age-specific annual incidence varied considerably, from 0.18/1000/year to 2.59/1000/year. Second, an age of less than two months, birthweight under 2000 g or prematurity under 37 weeks of gestation and CHD were independently significant risk factors for PICU admissions and the need for respiratory support. Third, the presence of apnoea was associated with the need for intensive care. Fourth, audible wheezes and coarse crackles were, interestingly, more common in controls treated in the ED or on the ward than in cases treated in the PICU for bronchiolitis.
A Finnish study found that the incidence of bronchiolitis admissions to the ED at less than six months of age was 37/1000/year and the age-specific population-based incidence of bronchiolitis treated in the PICU was 2.3/1000/ year in that age-specific population (4). The incidence was 1.5 times higher than the mean incidence of 1.5/1000/year in the present study, but the annual incidence varied considerably in our study. This variation was due to the low number of infants treated annually in the PICU and the variations in respiratory syncytial virus epidemics. The figures for the need of mechanical ventilation among those admitted to the PICU were 13% in the earlier study (4) and 20% in our study. In a 2014 Finnish study, the PICU treatment rate was 6.3% among those hospitalised for bronchiolitis at less than 12 months of age (5), but population-based incidence figures could not be calculated in that study. In England, admission rates to the PICU ranged from 1.3 to 1.6 per 1000 infants at less than 12 months of age between 2004 and 2012 (13). These incidence figures were surprisingly similar to the mean incidence in the present study. In another study, based on the nationally representative database on paediatric hospitalisations in the United States, the need for mechanical ventilation increased between 2000 and 2009 (3). Although the annual incidences varied considerably in the present study, no such trends were seen. Several studies have evaluated the clinical factors associated with cases of severe bronchiolitis using different outcomes, such as admission to the PICU (7,10,14-16), the need for mechanical ventilation (7) (8) (9) or the use of nCPAP (17) . Five studies were carried out prospectively (7) (8) (9) (10) 15) . However, none of the previous study groups were entirely comparable to our study group. Some studies included children over 12 months old (8, 10, 15, 16) and some included children with episodes of previous wheezing (8, 10, 16, 17) . In addition, some studies excluded children with an underlying disease and preterm birth (9, 14, 15) .
In line with our findings, PICU admissions and, or, the need for respiratory support were predicted by young age (8) (9) (10) 15, 16) and low birthweight (7, 8) in many studies. Two prospective multicentre studies highlighted that being less than two months old was a risk factor for PICU admission (10) and respiratory support (8) . In the present adjusted analyses, infants who were less than two months old had an 11.5-fold risk for PICU admission and a 10.2-fold risk for needing respiratory support. Similarly, an Italian study that used adjusted analyses confirmed that an age of less than one month predicted admission to the PICU and the need for respiratory support in hospitalised infants with bronchiolitis under the age of 12 months (9). We found that a birthweight of less than 2000 g was an independently significant risk factor for PICU admission and respiratory support. Similar birthweights of less than 2300 g were the cut-off limits that increased the risk of both intensive care and respiratory support in two other studies (7, 8) .
Prematurity is a known risk factor for needing hospitalisation for severe bronchiolitis (18, 19) . Only a few studies have identified premature birth as a risk factor for PICU admission or the need for respiratory support (16) . A retrospective hospital chart review published in 2015 concluded that premature birth was associated with PICU admission, but not to the length of PICU stay or treatment with mechanical ventilation (16) . We found that those infants with bronchiolitis who were born preterm had a 7.2-fold risk of being admitted to the PICU and a 6.7-fold risk of needing respiratory support. Preterm birth was an independently significant risk factor if low birthweight was not in the multivariable model, but due to the interaction, it lost its significance if low birthweight was in the model.
Congenital heart disease has been associated with higher hospitalisation rates in infants with bronchiolitis (20) , and haemodynamically significant CHD has been identified as a risk factor for severe bronchiolitis (18, 21) . Some earlier retrospective case-control studies focusing on complicated respiratory syncytial virus infections identified CHD as a risk factor for PICU admission, need of respiratory support, as well as a long duration of ventilation and PICU stay, in infants with bronchiolitis (22, 23) . In our present retrospective 16-year, case-control study, all the infants with CHD were more than two months of age. Finally, CHD was an independently significant risk factor for PICU admission and for respiratory support for infants older than two months, although, CHD was haemodynamically significant in less than 25% of CHD cases.
As expected, apnoea was an independently significant risk factor for PICU admission. A previous prospective multicentre study described apnoea as an independently significant risk factor for respiratory support (8), but we were not able to confirm that result, probably due to our retrospectively collected data on apnoea based on entries in hospital records. In a previous study, infants with apnoea were younger, more likely to be born preterm and had lower birthweights (24) , in accordance with our current observations. A prospective multicentre cohort study showed that 56% of the 108 bronchiolitis patients with documented apnoeas during their inpatient stay required intensive care (24) . In our study, 93% of infants with apnoeas during hospitalisation were admitted to the PICU and half of them required respiratory support.
In the present case-control study, audible wheezes and coarse crackles were more common among patients discharged from the ED or treated on the ward compared to those treated in the PICU. This was in line with a previous study on 583 children hospitalised for bronchiolitis at less than 24 months of age, which reported that wheezing was more common among those treated on the ward (80%) than in the PICU (60%) (10) . It is possible that wheezing indicates a less invasive disease and more reactive airways and that bronchiolitis with wheezing may be the first sign of asthma (25) . There is some indirect evidence for this assumption, as wheezing infants seem to be older (6) and to respond better to bronchodilators (26) , have more subsequent wheezing (27) and are more likely to be associated with viruses other than respiratory syncytial virus (25) , compared to nonwheezing infants with bronchiolitis. In particular, the first wheezing episode associated with a rhinovirus infection may the first sign of childhood asthma (28) .
The strength of this study was the carefully registered clinical data on admission and during hospitalisation in infancy, even though they were collected retrospectively. However, there was some information that was insufficient, such as information about parental smoking or the nonsystematic examination of viral findings. One of the authors reviewed all the patient records after the cases were identified from the electronic registers. This means that the established diagnoses were not accepted directly, but were always revisited based on the information registered in the patient records by the doctors and nurses.
The main shortcoming of this study was that the design was retrospective. On the other hand, organising prospective surveillance time that is long enough to include sufficient patients is laborious and expensive. The other shortcoming of this one-centre study was the small number of patients, even though the surveillance period was as long as 16 years.
CONCLUSION
The average age-specific annual incidence of bronchiolitis requiring intensive care at the age of less than 12 months was 1.5/1000/year, but varied considerably. The independently significant risk factors for PICU admission and respiratory support were being age less than two months, a birthweight under 2000 g or prematurity under 37 weeks and CHD. 
